Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Andersen

Showing results (21-30 of 197) with videos related to

Pageof 20
Sort By:
British Journal of Clinical Pharmacology|November 27, 2008
Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological modelHelle Wallach Kildemoes, Henrik Støvring, Morten Andersen
Pharmacoepidemiology and Drug Safety|October 19, 2010
The impact of ageing and changing utilization patterns on future cardiovascular drug expenditure: a pharmacoepidemiological projection approachHelle Wallach Kildemoes, Morten Andersen, Henrik Støvring
Mathematical Biosciences|September 10, 2013
Mathematical modeling of the hypothalamic-pituitary-adrenal gland (HPA) axis, including hippocampal mechanismsMorten Andersen, Frank Vinther, Johnny T Ottesen
Journal of Mathematical Biology|November 26, 2010
The minimal model of the hypothalamic-pituitary-adrenal axisFrank Vinther, Morten Andersen, Johnny T Ottesen
Ugeskrift for Laeger|March 7, 2009
[Drug marketing: methods, effect and regulation]Jens Søndergaard, Mette Marie Koefoed, Morten Andersen
Pharmacoepidemiology and Drug Safety|August 9, 2011
Drug utilization according to reason for prescribing: a pharmacoepidemiologic method based on an indication hierarchyHelle Wallach Kildemoes, Carsten Hendriksen, Morten Andersen
Mathematical Biosciences and Engineering : MBE|November 9, 2019
Mathematical analysis of the Cancitis model and the role of inflammation in blood cancer progressionZamra Sajid, Morten Andersen, Johnny T Ottesen
Basic & Clinical Pharmacology & Toxicology|October 28, 2023
Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare dataMia Aakjaer, Marie Louise De Bruin, Morten Andersen
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 9, 2017
Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort studyTomas Forslund, Björn Wettermark, Morten Andersen, et al.
Expert Opinion on Drug Safety|July 15, 2021
Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccinesMaurizio Sessa, Kristian Kragholm, Anders Hviid, et al.
Pageof 20

Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
British Journal of Clinical Pharmacology|November 27, 2008
Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological modelHelle Wallach Kildemoes, Henrik Støvring, Morten Andersen
Pharmacoepidemiology and Drug Safety|October 19, 2010
The impact of ageing and changing utilization patterns on future cardiovascular drug expenditure: a pharmacoepidemiological projection approachHelle Wallach Kildemoes, Morten Andersen, Henrik Støvring
Mathematical Biosciences|September 10, 2013
Mathematical modeling of the hypothalamic-pituitary-adrenal gland (HPA) axis, including hippocampal mechanismsMorten Andersen, Frank Vinther, Johnny T Ottesen
Journal of Mathematical Biology|November 26, 2010
The minimal model of the hypothalamic-pituitary-adrenal axisFrank Vinther, Morten Andersen, Johnny T Ottesen
Ugeskrift for Laeger|March 7, 2009
[Drug marketing: methods, effect and regulation]Jens Søndergaard, Mette Marie Koefoed, Morten Andersen
Pharmacoepidemiology and Drug Safety|August 9, 2011
Drug utilization according to reason for prescribing: a pharmacoepidemiologic method based on an indication hierarchyHelle Wallach Kildemoes, Carsten Hendriksen, Morten Andersen
Mathematical Biosciences and Engineering : MBE|November 9, 2019
Mathematical analysis of the Cancitis model and the role of inflammation in blood cancer progressionZamra Sajid, Morten Andersen, Johnny T Ottesen
Basic & Clinical Pharmacology & Toxicology|October 28, 2023
Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare dataMia Aakjaer, Marie Louise De Bruin, Morten Andersen
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 9, 2017
Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort studyTomas Forslund, Björn Wettermark, Morten Andersen, et al.
Expert Opinion on Drug Safety|July 15, 2021
Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccinesMaurizio Sessa, Kristian Kragholm, Anders Hviid, et al.
Pageof 20